[Collagenase injection in Dupuytren's disease, evaluation of the ultrasound assisted technique].

Leclère, Franck-Marie; Mathys, Lukas; Vögelin, Esther (2014). [Collagenase injection in Dupuytren's disease, evaluation of the ultrasound assisted technique]. Chirurgie de la main, 33(3), pp. 196-203. Elsevier Masson SAS 10.1016/j.main.2014.01.006

[img] Text
1-s2.0-S1297320314000316-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

Since October 2011, the enzymatic lysis of Dupuytren's cord was introduced in Switzerland (Xiapex(®), Auxilium Pharmaceuticals, Pfizer). Here we present our first university experience and underline the major role of ultrasound during the injection. Between December 2011 and February 2013, 52 injections were performed to eliminate 43 Dupuytren's cords in 33 patients. The mean age of the patients was 64.4 ± 8.5 years. Complications were documented for each patient. Before, directly after and after a minimum of 6 months post-injection, the contracture of the treated joint was measured with use of a goniometer. The DASH score was evaluated after a minimum of 6 months and the patients were asked to subjectively evaluate the outcome of the treatment (very good, good, mild, poor) and whether they would reiterate it if necessary. Four skin defects, one lymphangitis, and one CRPS were responsible for a complication rate of 18%. There was no infection and no tendon rupture in the series. The mean MCP joint contracture was respectively 36.8 ± 27.4°, 3.5 ± 7.8° (gain of mobility compared to the preoperative situation 33.3°, P<0.001), and 8.4 ± 13.9° (gain 28.4°, P<0.001) respectively before, just after and at the long-term clinical control. The mean PIP joint contracture was respectively 36.5 ± 29.1°, 5.9 ± 6.7° (gain 30.6°, P<0.001), and 15.1 ± 13.8° (gain 21.4°, P<0.001) respectively before injection, just after and at the long-term clinical control. The DASH score decreased from 24 ± 14 to 7 ± 9 (P<0.001). Eighty-one per cent of the patients were satisfied or very satisfied of the treatment. All but two would reiterate the treatment if necessary. Ultrasound is able to target the injection of collagenase in order to reduce complications. The short-term results of this non-invasive therapy are very promising however comparison with conventional procedures is difficult as the long-term results are lacking.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Plastic and Hand Surgery > Hand Surgery
04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Plastic and Hand Surgery
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Forschungsbereich Mu50 > Forschungsgruppe Handchirurgie

UniBE Contributor:

Leclère, Franck-Marie; Mathys, Lukas and Vögelin, Esther

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1297-3203

Publisher:

Elsevier Masson SAS

Language:

French

Submitter:

Jörg Arnoldi

Date Deposited:

05 Sep 2014 09:28

Last Modified:

06 Nov 2015 10:42

Publisher DOI:

10.1016/j.main.2014.01.006

PubMed ID:

24674697

Uncontrolled Keywords:

Collagenase Collagénase Cordes Cords Dupuytren Ultrasound Xiapex(®) Échographie

BORIS DOI:

10.7892/boris.58165

URI:

https://boris.unibe.ch/id/eprint/58165

Actions (login required)

Edit item Edit item
Provide Feedback